bioRxivPharmacology & ToxicologyPreprint
BCL-XL is essential for the protection from secondary anemia caused by radiation-induced fatal kidney damage
K. Brinkmann, P. Waring, S. Glaser, V. Wimmer, D. Nhu, L. Whitehead, A. R. Delbridge, G. Lessene, M. Herold, G. L. Kelly, S. Grabow, A. Strasser
Abstract
Studies of gene-targeted mice identified the roles of the different pro-survival BCL-2 proteins during embryogenesis, but less is known about the roles of these proteins in adults, including in the response to cytotoxic stresses, such as treatment with anti-cancer agents. We investigated the role of BCL-XL in adult mice using a strategy where prior bone marrow transplantation allowed for loss of BCL-XL exclusively in non-hematopoietic tissues to prevent anemia caused by BCL-XL-deficiency in erythroid cells. Unexpectedly, the combination of total-body {gamma}-irradiation (TBI) and genetic loss of Bcl-x caused secondary anemia resulting from chronic renal failure due to apoptosis of renal tubular epithelium with secondary obstructive nephropathy. These findings identify a critical protective role of BCL-XL in the adult kidney and inform on the use of BCL-XL inhibitors in combinations with DNA damage-inducing drugs for cancer therapy. SummaryThe inducible loss of BCL-XL in all cells of adult mice causes primary anemia due to apoptosis of erythroid and megakaryocytic cell populations. In contrast {gamma}-radiation plus loss of BCL-XL in all cells except hematopoietic cells causes secondary anemia resulting from kidney damage.
- organism: mouse
- research focus: host-pathogen & immune response
- research focus: cancer & tumor microenvironment
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Mesenchymal Tumor Cell State Confers Increased Dependency on the BCL-XL Anti-apoptotic Protein in Kidney Cancer
T. M. Grubb, S. Maganti, … A. Chakraborty·bioRxiv·Jan 29, 2022
- Conformational states of the cytoprotective protein Bcl-xL
P. Ryzhov, Y. Tian, … F. M. Marassi·bioRxiv·Mar 25, 2020
- Co-targeting BCL-XL and MCL-1 with DT2216 and AZD8055 synergistically inhibits small-cell lung cancer growth without causing on-target toxicities in mice
S. KHAN, P. Kellish, … D. Zhou·bioRxiv·Sep 12, 2022
- Requirement for Anti-Apoptotic MCL-1 during Early Erythropoiesis
Meghan E. Turnis, Ewa K. Kaminska, … Joseph T. Opferman·BloodPeer-reviewed·Apr 8, 2021
- Selective Vulnerability of Senescent Glioblastoma Cells to Bcl-XL Inhibition
M. Rahman, I. E. Olson, … E. F. Sananikone·bioRxiv·Jun 3, 2020
- Targeted anti-BCR-ABL+ ALL therapy may benefit the heart
H. Kirchhoff, M. Ricke-Hoch, … D. Hilfiker-Kleiner·bioRxiv·Jun 4, 2021